- Doctors & Departments
- Conditions & Advice
- Your Visit
- Research & Innovation
Better outcomes, improved care and an enhanced quality of life – these are the goals of the research conducted by the Section of Neonatology at Children's Hospital Colorado.
Our team strives to elevate care for the smallest, most vulnerable patients. We continue to innovate, regularly ushering in new discoveries, practices and techniques from the lab to the bedside.
Children's Colorado has partnered with Mayo Clinic to study the use of stem cell therapy for hypoplastic left heart syndrome (HLHS). Learn more about our first patient.
With a focus on each child's long-term quality of life, our physicians in the Section of Neonatology develop new therapies and innovate treatments for complex neonates.
The neonatal doctors at our Level IV NICU have had a hand in developing several standard NICU treatments and, in many cases, were the first in the world to use these therapies.
Here at the Section of Neonatology and the Perinatal Research Center, we've played an integral role in neonatology advancements, serving as:
"Our goal is to help mothers make informed decisions about their own health."
Erica Wymore, MD
NeonatologistLearn about Dr. Wymore's research
Our doctors and researchers conduct basic science, clinical and medical education research, and lead research efforts and initiatives in:
Our Section of Neonatology's basic science research is the foundation for the application of new therapies and approaches to care for neonates and infants in the NICU. Our ongoing basic science research:
The clinical researchers at Children's Colorado seek to continually improve the diagnosis, treatment and outcomes of neonates. Ongoing clinical research includes:
While our basic science and clinical research programs continue to lead to advancements in the neonatal care for premature and medically complex infants, our research extends beyond the bench and bedside:
Study Title: Sanford Children’s Genomic Medicine Consortium
Purpose: Children's Hospital Colorado is one of six founding pediatric hospitals to form the Sanford Children’s Genomic Medicine Consortium. The cutting-edge collaboration will focus on researching genomic medicine, which uses genetic and genomic information to personalize care for each child. Through innovative joint research programs that utilize the large scale and a diverse research population of the participating hospitals, the consortium hopes to expedite genomic and genetic discoveries. The personalized care that evolves from these discoveries will improve treatment outcomes for both common and rare childhood diseases.
Read about our participation in Sanford Children’s Genomic Medicine Consortium.
The research that the physician-scientists conduct in our Section of Neonatology means our Level IV NICU is able to provide the highest level of care for any condition that may affect a newborn – no matter how rare or critical.
It means that our outcomes remain above the standard, even as the complexity and acuity of our patients increase.
Our neonatal medicine research aims to create a future where there are:
Learn more about the Section of Neonatology.